United States Cutaneous Lymphoma Consortium

Analysis

United States Cutaneous Lymphoma Consortium is a registered charity in United States, based in Mechanicsburg, PA. It received its IRS tax-exemption ruling in November 2009, 17 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, United States Cutaneous Lymphoma Consortium reported income of $233k and spending of $230k, spending 99% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $182k to $233k (+28%), an average of +6.4% a year. The sharpest change came in the year to December 2022, when income rose by 209%. Over the whole period it spent 82% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, United States Cutaneous Lymphoma Consortium sits at the 43rd percentile: it is larger than about 43% of them. Against every charity in United States with reported income it ranks in the 57th percentile, and in the 55th percentile within PA. Charities of a similar size with the same main cause include Health Camp of New Jersey Inc ($233k), Bradford Healthcare Foundation ($233k) and Financial Assistance for Cancer Treatment Inc ($233k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 44% and program service revenue 56% of the total. At year end it held assets of $712k against liabilities of $9,306, net assets of $703k.